Scientech Research LLC’s Novo Nordisk NVO Stock Holding History

Scientech Research LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$341K	Buy	+9,274	New	+$439K	0.28%	101
2025 Q4	–	Sell	-19,624	Closed	-$1.09M	–	714
2025 Q3	$1.09M	Buy	+19,624	New	+$1.15M	0.38%	37
2025 Q1	–	Sell	-4,283	Closed	-$368K	–	738
2024 Q4	$368K	Buy	+4,283	New	+$463K	0.1%	376
2024 Q3	–	Sell	-3,269	Closed	-$467K	–	774
2024 Q2	$467K	Buy	+3,269	New	+$433K	0.1%	349

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Scientech Research LLC's NVO Position: Q1 2026 in Review

Scientech Research LLC opened a new position in Novo Nordisk (NVO) in Q1 2026: 9,274 shares worth $341K. The stake represents 0.28% of the portfolio and ranks #101 among its holdings. This is a return to the name: Scientech Research LLC previously reported a position in NVO as recently as Q3 2025.

Scientech Research LLC first reported a position in NVO in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.09M in Q3 2025. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Scientech Research LLC held 9,274 shares of Novo Nordisk worth $341K as of Q1 2026.
Novo Nordisk was a new Scientech Research LLC position in Q1 2026.
Novo Nordisk made up 0.28% of Scientech Research LLC's portfolio in Q1 2026, its #101 holding.
Scientech Research LLC first reported a position in Novo Nordisk in Q2 2024 and has held it in 4 quarters since.
Scientech Research LLC's Novo Nordisk position peaked at $1.09M in Q3 2025.
1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.